Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis by Rony Chanoch-Myers, Adi Wider, Mario L. Suva, Itay Tirosh

Get full text

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model by J. Bryan Iorgulescu, J. Bryan Iorgulescu, J. Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, Ryuhjin Ahn, Eleni Panagioti, Prafulla C. Gokhale, Martha Neagu, Maria C. Speranza, Benjamin K. Eschle, Kara M. Soroko, Raziye Piranlioglu, Meenal Datta, Meenal Datta, Shanmugarajan Krishnan, Kathleen B. Yates, Kathleen B. Yates, Gregory J. Baker, Gregory J. Baker, Rakesh K. Jain, Mario L. Suvà, Mario L. Suvà, Mario L. Suvà, Donna Neuberg, Forest M. White, Forest M. White, E. Antonio Chiocca, Gordon J. Freeman, Arlene H. Sharpe, Arlene H. Sharpe, Arlene H. Sharpe, Catherine J. Wu, Catherine J. Wu, David A. Reardon

Get full text

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1 by Ling Hai, Dirk C. Hoffmann, Robin J. Wagener, Daniel D. Azorin, David Hausmann, Ruifan Xie, Magnus-Carsten Huppertz, Julien Hiblot, Philipp Sievers, Sophie Heuer, Jakob Ito, Gina Cebulla, Alexandros Kourtesakis, Leon D. Kaulen, Miriam Ratliff, Henriette Mandelbaum, Erik Jung, Ammar Jabali, Sandra Horschitz, Kati J. Ernst, Denise Reibold, Uwe Warnken, Varun Venkataramani, Rainer Will, Mario L. Suvà, Christel Herold-Mende, Felix Sahm, Frank Winkler, Matthias Schlesner, Wolfgang Wick, Tobias Kessler

Get full text